A

Angeles Therapeutics, Inc.

10 employees

Angeles Therapeutics chimeric antigen receptor T (CAR-T) platform targeting more than 130 antigens covering cancer, and immune disorders.

Basic info

Industry

biotechnology research

Sectors

CAR-NK

Biopharma

Cell therapy

CAR-T

Immune therapies

SIR-T

Medical

Health Care

Cancer therapies

Date founded

2018

FAQ